alexa A Novel Perspective on Dopaminergic Processing of Human Addiction | OMICS International
ISSN: 2329-6488
Journal of Alcoholism & Drug Dependence
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

A Novel Perspective on Dopaminergic Processing of Human Addiction

Rajendra D Badgaiyan1,2*

1Department of Psychiatry, State University of New York at Buffalo, USA

2Department of Psychiatry, VA Medical Center, Buffalo, NY, USA

*Corresponding Author:
Rajendra Badgaiyan
Department of Psychiatry, State
University of New York at Buffalo, USA
Tel: 716-580-3063
E-mail: [email protected]

Received date: October 25, 2012; Accepted date: October 26, 2012; Published date: October 29, 2012

Citation: Badgaiyan RD (2013) A Novel Perspective on Dopaminergic Processing of Human Addiction. J Alcoholism Drug Depend 1:e101. doi:10.4172/2329-6488.1000e101

Copyright: © 2013 Badgaiyan RD. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Alcoholism & Drug Dependence

It is known for the past several years that dopamine is involved in addictive process. Its precise role however, remains uncertain because of the lack of clarity on neurocognition of addiction. Two of the influential models of addiction appear to have divergent views on the neurocognition. The hedonic homeostasis model suggests that addicts require a higher level of the brain dopamine to feel rewarded [1]. It suggests that increased mesolimbic activation caused by initial drug use hyper-activates the reward system and up-regulates set point of hedonic homeostasis. Because of the up regulation the brain needs to maintain a higher level of dopamine, forcing individuals to seek drugs that raise dopamine levels. An alternate model, the associative memory model, suggests that addiction is primarily a cognitive disorder in which associative memory is pathologically subverted [2]. Because of this subversion, the reward associated with an addictive substance acquires motivational value and initiates drug-seeking behavior. Even though both models suggest that the dopamine system is dysregulated in addiction, it appears that the two models have different views on how altered dopamine neurotransmission leads to addiction. The hedonic homeostasis hypothesis assumes that addicts need higher levels of dopamine to activate the reward system and associative memory hypothesis suggests that the altered levels of dopamine impairs processing of associative memory. The two assumptions however may be complementary because as discussed in the following paragraphs, processing of both, associative memory and reward is dependent on dopamine neurotransmission. Thus, a dysregulated dopamine system is expected to impair both of these functions.

The role of dopamine in reward processing has been extensively studied in laboratory animals [3,4]. These studies have found that the reward system is regulated by dopamine released in the mesocortical pathway. It has been shown that delivery of award is associated with short phasic bursts of dopamine. These bursts disappear when the reward is predictable, and reappear if it is better than expected. If reward is withheld, the tonic release is suppressed at the expected time of delivery. Thus, changes in the phasic and tonic release of dopamine signal the nature of reward and allow the brain to make decisions based on the reward quality. Some of the findings of animal experiments are consistent with observation of molecular imaging experiments on healthy volunteers. In these experiments the binding potentials (BP) of dopamine receptor ligands measured under the baseline condition were compared with those measured during performance of a reward task. The comparison revealed that the BP is reduced (suggesting increased dopamine release) in the striatum in a number of task conditions involving reward [5]. However, these results need to be verified because using a more sensitive single scan dynamic molecular imaging technique; we observed dopamine release in the same striatal areas in an unrewarded task [6]. Additionally, while these experiments found activation both in the dorsal and ventral striatum, in animals reward is processed primarily in the ventral striatum [3]. Thus, if molecular imaging data are verified, a major difference in dopaminergic processing of human and animal reward systems could be revealed. It will have implications on neurocognitive models of addiction because these models are based on animal data.

Associative memory has also been studied both in animals and in human volunteers. These studies have found that repeated paired delivery of a stimulus and reward sensitizes the neural system [7]. Because of this sensitization behavioral response to a previously exposed drug increases significantly when it is administered in the same cage where the drug was previously delivered. It appears that the animal makes an association between the environment (cage) and drug. It was also shown that this associative context acquires motivational significance after repeated pairing of the drug and environment [8]. Due to this motivation rats develop conditioned place preference and spend more time in the location where they Received date: drug. The place preference therefore suggests establishment of an association between the drug and place of delivery. The brain area where this association is processed is not known but the nucleus accumbens (NAc) appears to be one of the possible locations. Experiments have shown that both, psychostimulants and non-stimulant addictive drugs increase dopaminergic activity in the NAc in rats [9]. Since increased dopamine concentration in this area (along with prefrontal cortex) is observed also during conditioned learning, it appears that the drug-induced dopamine release in the NAc represents learning of the association between drug and drug related cues. Because of this association, cues are known to trigger dopaminergic response similar to the one triggered by reward itself. Thus in rats, after a smell is repetitively and predicatively paired with food, increased concentration of dopamine is observed in the core of the NAc and in the frontal cortex even when these stimuli are presented without food reward [10]. The NAc however does not appears to have this role in primates. In monkeys its activities are more closely associated with the reward prediction error [3] and in healthy volunteers tasks that require association activate dorsal striatal structures [6,11-13]. In another experiment dopamine release in this area was observed in cocaine addicts when they were shown videos portraying people smoking cocaine [14]. These observations indicate that in the human brain dopamine of dorsal striatum is involved in the processing of association between a cue and a reward [15]. Further evidence of dopaminergic involvement in associative process comes from pharmacological studies. These studies have demonstrated that blockade of D1 receptors prevents formation of an association between drug and its environment and its agonists enhance acquisition of conditioned response [16].

Thus, dopamine influences addictive process at multiple levels. It was suggested that in the ventral striatum it facilitates acquisition of drug seeking behavior and in the dorsal striatum, dopamine helps transition of this behavior to addiction [8]. Evidence suggests that the motivational aspect of addiction is processed in the NAc. Therefore, when its dopamine receptors are blocked, the motivation is reduced in animals [17]. The agonists on the other hand, enhance motivation [18]. Interestingly, lesion of the NAc blocks motivation for drugs but do not affect motivation for food reward. It therefore appears that the NAc regulates processing of only secondary motivational stimuli - the stimuli that acquire motivational values by associative learning [19]. This function is partly controlled by input from the amygdala where emotional and motivational significance of stimuli is processed. The dorsal striatal structures are also involved in processing of dopamine-dependent associative memory. In these structures, dopamine modulates activity of the tonically active neurons, which regulate mnemonic functions of the striatum. Enhanced dopamine activity in the dorsal striatum therefore improves memory. As a result, animals perform better in conditioning experiments if they receive amphetamine in the caudate after the training [20].

The data acquired in animal experiments however do not fully explain human addiction because of specific social, cultural and psychological issues that are associated with addictive behavior. However human studies also suggest dysregulated dopamine neurotransmission in addiction. These studies have found that in chemical dependent individuals the striatal and prefrontal activities are altered both at the baseline and during exposure to drug or drug-related cues [14]. The orbitofrontal cortex in particular shows strong abnormal activity in addicts, probably because of its involvement in the processing of psychosocial cues, which are known to modify addictive behavior and considered important trigger for relapse. Irrespective of the trigger however, relapse is dependent on the level of dopaminergic activity. Modeling experiments suggest that a low level of phasic activity (indicated by increased frequency and duration of pauses between phasic dopamine release) reinstitutes suppressed memories of association between the cue and drug reward leading to relapse [21].

Further, the observation suggesting dopaminergic processing of associative learning in animals, discussed above, is consistent with the findings of our molecular imaging experiments. In these experiments we found dopamine release in the striatum of healthy volunteers during performance of tasks that require establishment of an association between a stimulus and motor response [6,12,13].

Future Perspective

It is clear from the above discussion that dopamine influences addictive behavior by altering cognitive processing associated with memory and reward. However most of the data discussed were obtained in laboratory animals. The data on the role of dopamine on human addiction is extremely limited because of the lack of a reliable technique to study neurotransmission in the live human brain. However, recent advances in dynamic molecular imaging technique implemented in our laboratory [6,11-13,22-26] and elsewhere [27] has allowed use of these techniques for detection, mapping and measurement of acutely released dopamine. Using this technique we detected, mapped, and measured dopamine released during processing of cognitive, emotional, and behavioral tasks [6,11-13,22-26]. There is therefore a need to use dynamic molecular imaging technique to acquire data on human addiction and to examine the role of dopamine neurotransmission.

Acknowledgements

This work was partially supported by the National Institutes of Health grants 1R01NS073884 and 1R21MH073624; and the VA Merit Review Awards CX000479 and CX000780.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 11795
  • [From(publication date):
    January-2013 - Feb 23, 2018]
  • Breakdown by view type
  • HTML page views : 7985
  • PDF downloads : 3810
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version